Roberts Kent Charles II 4
4 · BIOLARGO, INC. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
Roberts Kent Charles II
Director
Transactions
- Award
Option to purchase common stock
2022-03-31+4,167→ 2,320,645 totalExercise: $0.23From: 2022-03-31Exp: 2032-03-31→ Common stock (4,167 underlying)
Footnotes (1)
- [F1]This Option was granted to Reporting Person to replace option(s) previously issued in lieu of cash compensation to Reporting Person for services provided to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price of the Option and the current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.